Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Improving Care for Patients With Stage III or IV NSCLC: Learnings for Multidisciplinary Teams From the ACCC National Quality Survey.
Precision medicine and actionable alterations in lung cancer: A single institution experience.
RLIP controls receptor-ligand signaling by regulating clathrin-dependent endocytosis.
Disparate outcomes in nonsmall cell lung cancer by immigration status.
FAK and paxillin, two potential targets in pancreatic cancer.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
FAK and paxillin, two potential targets in pancreatic cancer.
FAK and paxillin, two potential targets in pancreatic cancer. Oncotarget. 2016 May 24; 7(21):31586-601.
View in:
PubMed
subject areas
Biomarkers, Tumor
Carcinoma, Pancreatic Ductal
Focal Adhesion Kinase 1
Humans
Models, Biological
Molecular Targeted Therapy
Pancreatic Neoplasms
Paxillin
Protein Kinase Inhibitors
Signal Transduction
authors with profiles
Ravi Salgia